Syndax Pharmaceuticals Inc
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 535 | 0.0% | 25,461 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 413 | 0.0% | 44,149 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 512 | 0.0% | 41,670 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 567 | 0.0% | 42,890 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 918 | 0.0% | 47,704 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 999 | 0.0% | 48,668 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 998 | 0.0% | 41,913 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 733 | 0.0% | 33,924 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 496 | 0.0% | 34,138 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 557 | 0.0% | 26,620 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 456 | 0.0% | 21,610 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 523 | 0.0% | 20,551 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 481 | 0.0% | 20,034 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 393 | 0.0% | 20,435 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 335 | 0.0% | 19,297 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 509 | 0.0% | 23,256 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 456 | 0.0% | 23,884 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 439 | 0.0% | 25,570 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 403 | 0.0% | 18,007 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 370 | 0.0% | 16,637 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 242 | 0.0% | 16,391 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 237 | 0.0% | 16,391 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 158 | 0.0% | 14,435 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 116 | 0.0% | 13,214 | 12/31/2019 |